Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction

Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction

Purpose: In this study, we aimed to evaluate the clinical utility of the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), and monocyte/high-density lipoprotein cholesterol ratio (MHR) in predicting response to a phosphodiesterase type 5 inhibitor (...

Full description

Bibliographic Details
Main Authors: Metin Kilic, Anil Erkan, Salim Zengin, Gokce Dundar, Caglar Boyaci
Format: Article
Language:English
Published: Korean Urological Association 2023-07-01
Series:Investigative and Clinical Urology
Subjects:
erectile dysfunction
high-density lipoprotein
lymphocyte
monocyte
phosphodiesterase 5 inhibitors
Online Access:https://www.icurology.org/pdf/10.4111/icu.20230013

Internet

https://www.icurology.org/pdf/10.4111/icu.20230013

Similar Items